| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Camp4 Therapeutics Corp | Director | Common Stock | 170K | $281K | $1.65 | Sep 11, 2025 | Direct |
| Syros Pharmaceuticals, Inc. | Director | Common Stock | 10.7K | $17.9K | $1.68 | Sep 16, 2024 | Direct |
| Syros Pharmaceuticals, Inc. | Director | Restricted Stock Units | 2.67K | $4.47K | $1.68 | Sep 16, 2024 | Direct |
| Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25K | Jun 20, 2024 | Direct | ||
| Camp4 Therapeutics Corp | Director | Stock Option (Right to Buy) | 9K | Jun 25, 2025 | Direct | ||
| Syros Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 6K | Jun 5, 2024 | Direct | ||
| Camp4 Therapeutics Corp | Director | Series A Prime Preferred Stock | 0 | Oct 15, 2024 | Direct |